Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma.
Deleuran
Bent
B
Department of Rheumatology, Aarhus University Hospital, Denmark. b.deleuran@immunology.au.dk
Abraham
David J
DJ
D015496:CD4-Positive T-Lymphocytes / Q000473:pathology* / Q000502:physiology; D006801:Humans; D020381:Interleukin-17 / Q000502:physiology; D015850:Interleukin-6 / Q000502:physiology; D007378:Interleukins / Q000502:physiology; D012595:Scleroderma, Systemic / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology; D006377:T-Lymphocytes, Helper-Inducer / Q000473:pathology* / Q000502:physiology; D050378:T-Lymphocytes, Regulatory / Q000473:pathology / Q000502:physiology; D000097043:Interleukin-22
D020381:Interleukin-17; D015850:Interleukin-6; D007378:Interleukins; D000097043:Interleukin-22